Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 71, n° 1
pages 170-176 (juillet 2014)
Doi : 10.1016/j.jaad.2013.12.022
accepted : 17 December 2013
Reviews

Malassezia infections: A medical conundrum
 

Ana Filipa Pedrosa, MD a, b, , Carmen Lisboa, MD, PhD a, b, Acácio Gonçalves Rodrigues, MD, PhD a
a Department of Microbiology, Faculty of Medicine, University of Porto, Porto, Portugal 
b Department of Dermatology and Venereology, Centro Hospitalar São João EPE, Porto, Portugal 

Reprint requests: Ana Filipa Pedrosa, MD, Department of Microbiology, Faculty of Medicine, University of Porto, Portugal Alameda Professor Hernani Monteiro, 4200-319 Porto, Portugal.
Abstract

Malassezia yeasts have long been considered commensal fungi, unable to elicit significant damage. However, they have been associated with a diversity of cutaneous diseases, namely pityriasis versicolor, Malassezia folliculitis, seborrheic dermatitis, atopic dermatitis, psoriasis, and confluent and reticulate papillomatosis. Several hypotheses have been proposed to explain the pathogenic mechanisms of these fungi, but none have been confirmed. More recently, such organisms have been increasingly isolated from bloodstream infections raising serious concern about these fungi. Given the difficulty to culture these yeasts to proceed with speciation and antimicrobial susceptibility tests, such procedures are most often not performed and the cutaneous infections are treated empirically. The recurring nature of superficial skin infections and the potential threat of systemic infections raise the need of faster and more sensitive techniques to achieve isolation, identification, and antimicrobial susceptibility profile. This article reviews and discusses the latest available data concerning Malassezia infections and recent developments about diagnostic methods, virulence mechanisms, and susceptibility testing.

The full text of this article is available in PDF format.

Key words : antifungal agents, dermatomycoses, fungemia, Malassezia , pityriasis versicolor, seborrheic dermatitis



 Funding sources: None.
 Conflicts of interest: None declared.



© 2014  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline